Ann: Quarterly Results and Investor Conference Call Notification, page-25

Hey theoc, just to clarify, we do indeed have signed agreements and are bringing in revenue from these partners.

While it's still in the early stages, we are live with Medgate, Alodokter etc...however as uptake is just starting, I imagine Pfizer are using this to their advantage to say that the company is only worth 11.5 cents per share.

While I'm very interested in this upcoming quarterly results, even if revenue hasn't grown much, I am very bullish on RAP as it stands. Pfizer have revealed their desire for the company (albeit with a paltry offer) and have inadvertently put the eyes of many people around the world on us.

I'm not worried about any other bids to be honest. RAP has an insane amount of potential right now and I'd probably prefer a partnership with a big company moving forward anyway as opposed to an outright takeover.